Loading clinical trials...
Loading clinical trials...
A Randomized Trial of Treatment De-Escalation for HPV-Associated Oropharyngeal Squamous Cell Carcinoma: Radiotherapy vs. Trans-Oral Surgery (ORATOR II)
Conditions
Interventions
Radiation
Transoral Surgery (TOS) + Neck Dissection
Locations
9
Australia
Gold Coast University Hospital
Gold Coast, Queensland, Australia
Royal Adelaide Hospital
Adelaide, Australia
Tom Baker Cancer Centre
Calgary, Alberta, Canada
BC Cancer
Vancouver, British Columbia, Canada
London Regional Cancer Program
London, Ontario, Canada
Ottawa Hospital Research Institute
Ottawa, Ontario, Canada
Start Date
January 26, 2018
Primary Completion Date
August 15, 2028
Completion Date
August 15, 2028
Last Updated
January 28, 2026
NCT07209189
NCT06902623
NCT05375266
NCT03822897
NCT04432597
NCT03224000
Lead Sponsor
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions